(Last updated : 2024-04-28 14:09:03)
|
■ Journal
1.
|
|
Risk factors of treatment discontinuation due to uterine bleeding in adenomyosis patients treated w 2012/04
|
2.
|
|
Molecular genetic analysis of nongestational choriocarcinoma in a postmenopausal woman: a case repo 2012/07
|
3.
|
|
The cancer stem cell marker CD133 interacts with plakoglobin and controls desmoglein-2 protein levels. 2013/01/10
|
4.
|
|
ASBEL, an ANA/BTG3 antisense transcript required for tumorigenicity of ovarian carcinoma. 2013/02/13
|
5.
|
|
Somatic copy number alterations associated with Japanese or endometriosis in ovarian clear cell adenocarcinoma. 2015/02/06
|
6.
|
|
Use of dienogest over 53 weeks for the treatment of endometriosis. 2015/12/01
|
7.
|
|
Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes. 2017/06/01
|
8.
|
|
Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutation. 2017/06/08
|
9.
|
|
TERT promoter mutation in adult granulosa cell tumor of the ovary 2018/07/31
|
Display 5 items
|
Display all(9)
|
|
■ Academic background
|
■ Presentation
1. |
Targeting FOXL2 In A Model Of Adult-Type Granulosa Cell Tumor Of The Ovary
High-Throughput selection of tumor specific FOXL2C134W inhibitors (Poster notice,General) 2014/06
|
2. |
High-Throughput Drug Screening Of Adult-Type Granulosa Cell Tumor Of The Ovary Targeting FOXL2 C134W Mutation And Granulosa Cell (Poster notice,General) 2015/10/04
|
3. |
FOXL2 copy number is predictive of early recurrent adult type granulosa cell tumor of the ovary (Poster notice,General) 2017/04/14
|
|
■ Business career
|
■ Main Subject
|
■ Qualification and license
1. |
2023/02 |
Japan Society of Gynecologic Robotic Surgery
|
|
■ Research topic, funded research, and department laboratory expense
|
■ Present specialized field
Obstetrics and gynecology, Molecular biology
|
|
■ Department laboratory expense researcher number
|
■ External Researcher ID
orcID |
0000-0001-6699-4528
|
|